Navigating toward fetal and maternal health: The challenge of treating epilepsy in pregnancy

Epilepsia

Volumn 45, Issue 10, 2004, Pages 1171-1175

  Tomson, Torbjörn ^a   Perucca, Emilio ^b   Battino, Dina ^c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF PAVIA   (Italy)

^c DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

Antiepileptic drugs; Birth defects; Epilepsy; Pregnancy; Teratogenicity

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; FOLIC ACID; LAMOTRIGINE; PHENYTOIN; VALPROIC ACID;

CONCEPTION; DISEASE CLASSIFICATION; EPILEPSY; FAMILY HISTORY; FETUS MALFORMATION; HIGH RISK PREGNANCY; HUMAN; MATERNAL WELFARE; MONOTHERAPY; NORTH AMERICA; PRACTICE GUIDELINE; PREGNANCY COMPLICATION; PRIORITY JOURNAL; REGISTER; REVIEW; TERATOGENICITY; UNITED KINGDOM;

ABNORMALITIES, DRUG-INDUCED; ADULT; ANTICONVULSANTS; CARBAMAZEPINE; CHILD; COHORT STUDIES; CONFOUNDING FACTORS (EPIDEMIOLOGY); EPILEPSY; FEMALE; HUMANS; MATERNAL WELFARE; PHYSICIAN'S PRACTICE PATTERNS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; REGISTRIES; RESEARCH DESIGN; RISK FACTORS; TRIAZINES; VALPROIC ACID;

EID: 5344272596     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0013-9580.2004.15104.x     Document Type: Review

References (32)

1. Meadow SR. Anticonvulsant drugs and congenital abnormalities. Lancet 1968;2:1296.
2. Commission on Genetics, Pregnancy, and the Child, International League Against Epilepsy. Guidelines for the care of epileptic women of childbearing age. Epilepsia 1989;30:409-10.
3. Commission on Genetics, Pregnancy and the Child, International League against Epilepsy. Guidelines for the care of women of child-bearing age with epilepsy. Epilepsia 1993;34:588-9.
4. Committee on Educational Bulletins of the American College of Obstetricians and Gynecologists: ACOG educational bulletin. Seizure disorders in pregnancy. Int J Gynaecol Obstet 1997;56:279-86.
5. Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: management issues for women with epilepsy (summary statement). Neurology 1998;51:944-8.
6. Crawford P, Appleton R, Betts T, et al. The Women with Epilepsy Guidelines Development Group: best practice guidelines for the management of women with epilepsy. Seizure 1999;8:201-17.
7. SIGN. Diagnosis and management of epilepsy in adults: a national clinical guideline recommended for use in Scotland. Available from http://www.sign.ac. uk. Edinburgh: Scottish Intercollegiate Guidelines Network, 2003.
8. NHS. Newer drugs for epilepsy in adults. Available from http://www.nice.org.uk/pdf/TA076fullguidance.pdf [Accessed 2004 March]. London: National Institute for Clinical Excellence, 2004.
9. Delgado-Escueta AV, Janz D. Consensus guidelines: preconception counseling, management, and care of the pregnant woman with epilepsy. Neurology 1992;42(4 suppl 5):149-60.
10. Tomson T, Gram L, Sillanpää M, et al. Epilepsy and pregnancy. Petersfield: Wrightson Biomedical Publishing, 1997.
11. Samren EB, van Duijn CM, Koch S, et al. Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy. Epilepsia 1997;38:981-90.
12. Samren EB, van Duijn CM, Christiaens GC, et al. Antiepileptic drug regimens and major congenital abnormalities in the offspring. Ann Neurol 1999;46:739-46.
13. Olafsson E, Hallgrimsson JT, Hauser WA, et al. Pregnancies of women with epilepsy: a population-based study in Iceland. Epilepsia 1998;39:887-92.
14. Canger R, Battino D, Canevini MP, et al. Malformations in offspring of women with epilepsy: a prospective study. Epilepsia 1999;40:1231-6.
15. Kaneko S, Battino D, Andermann E, et al. Congenital malformations due to antiepileptic drugs. Epilepsy Res 1999;33:145-58.
16. Holmes LB, Harvey EA, Coull BA, et al. The teratogenicity of anticonvulsant drugs. N Engl J Med 2001;344:1132-8.
17. Kaaja E, Kaaja R, Hiilesmaa V. Major malformations in offspring of women with epilepsy. Neurology 2003;60:575-9.
18. Vajda FJ, O'Brien TJ, Hitchcock A, et al. The Australian registry of anti-epileptic drugs in pregnancy: experience after 30 months. J Clin Neurosci 2003;10:543-9.
19. Sabers A, Dam M, Rogvi-Hansen B, et al. Epilepsy and pregnancy: lamotrigine as main drug used. Acta Neurol Scand 2004;109:9-13.
20. Wide K, Winbladh B, Källén B. Major malformations in infants exposed to antiepileptic drugs in utero, with emphasis on carbamazepine and valproic acid: a nation-wide population-based register study. Acta Paediatr 2004;93:174-6.
21. Tennis P, Eldridge RR. Preliminary results on pregnancy outcomes in women using lamotrigine. Epilepsia 2002;43:1161-7.
22. North American Registry for Epilepsy and Pregnancy. A unique public/private partnership of health surveillance. Epilepsia 1998;39:793-8.
23. Morrow J. Which antiepileptic drug is safest in pregnancy? [Abstract]. Epilepsia 2003;44(suppl 8):60.
24. Tomson T, Battino D, Beaussart M, et al. EURAP: an international pregnancy registry for the evaluation of the comparative teratogenic effects of antiepileptic drugs [Abstract]. Epilepsia 2001;42(suppl 7):293.
25. Holmes L, Lieberman ES. Report of first positive findings from hospital-based AED pregnancy registry [Abstract]. Teratology 2001;63:250.
26. Holmes L, Wyszynski D, Mittendorf R. Evidence for an increased risk of birth defects in the offspring of women exposed to valproate during pregnancy: findings from the AED pregnancy registry [Abstract]. Am J Obstet Gynecol 2002;187(suppl):S 137.
27. Duncan S, Mercho S, Lopes-Cendes I, et al. Repeated neural tube defects and valproate monotherapy suggest a pharmacogenetic abnormality. Epilepsia 2001;42:750-3.
28. Malm H, Kajantie E, Kivirikko S, et al. Valproate embryopathy in three sets of siblings: further proof of hereditary susceptibility. Neurology 2002;59:630-3.
29. Gaily E, Kantola-Sorsa E, Granström ML. Intelligence of children of epileptic mothers. J Pediatr 1988;13:677-84.
30. Wide K, Henning E, Tomson T, et al. Psychomotor development in preschool children exposed to antiepileptic drugs in utero. Acta Paediatr 2002;91:409-14.
31. Gaily E, Kantola-Sorsa E, Hiilesmaa V, et al. Normal intelligence in children with prenatal exposure to carbamazepine. Neurology 2004;62:28-32.
32. Adab N, Jacoby A, Smith D, et al. Additional educational needs in children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry 2001;70:15-21.